Pfizer agrees to pay $93 mln to settle Lipitor antitrust lawsuit

Pfizer (PFE.N) has agreed to pay $93 million to settle antitrust claims by wholesale drug distributors that accused it of conspiring with India's Ranbaxy Laboratories to delay sales of less expensive, generic versions of the cholesterol drug Lipitor.